SBIR/STTR Research Award
VACCINATION AGAINST HOOKWORM WITH RECOMBINANT ANTIGENS
Award amount
$149,657Program and phase
SBIR · Phase IAward year
1999Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- Not reported
- Recipient company
- L2 DIAGNOSTICS LLC
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- GKA7VH5LFR25
- Solicitation number
- Not reported
- Topic code
- Not reported
Research abstract
Not Available Chemical weapons are highly lethal, inexpensive weapons of mass destruction. Present methods for detection of exposure to sulfur mustard are expensive and time-consuming. Accordingly, there is an urgent need for the development of rapid, simple, and reliable detection methods capable of monitoring of toxic compounds for clinical treatment and diagnosis after exposure to sulfur mustard. In phase I, we propose the syntheses of four analogs of bis ((2-acetylamino-2-carboxyethylthio) ethyl) sulfone and their conjugates with two carrier proteins (KLH and BSA) for production of antibodies and immunoassay development. Haptens will be coupled with carrier proteins through either the central sulfur atom or terminal amino group via a linker. BENEFITS: An immunoassay for rapid determination of exposure to sulfur mustard would contribute to improved diagnosis and treatment of individuals during military or terroristic acts.
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- A vaccine targeting mosquito metabolic pathways to eradicate malaria
- PfAg, a multivalent peptide vaccine against malaria
- A Point of Care Test for Babesia microti
- Novel Diagnostic Biomarker Discovery and Validation for Malaria
- THERAPEUTIC VACCINE PLATFORM TO BOOST IMMUNE RESPONSES IN TUBERCULOSIS